Cesare Orlandi
2017
In 2017, Cesare Orlandi earned a total compensation of $1.1M as Chief Medical Officer at Lantheus Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $281,038 |
|---|---|
| Salary | $402,802 |
| Stock Awards | $356,635 |
| Other | $12,150 |
| Total | $1,052,625 |
Orlandi received $402.8K in salary, accounting for 38% of the total pay in 2017.
Orlandi also received $281K in non-equity incentive plan, $356.6K in stock awards and $12.2K in other compensation.
Rankings
In 2017, Cesare Orlandi's compensation ranked 8,751st out of 14,666 executives tracked by ExecPay. In other words, Orlandi earned more than 40.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,751 out of 14,666 | 40th |
Division Manufacturing | 3,332 out of 5,768 | 42nd |
Major group Chemicals And Allied Products | 1,128 out of 2,074 | 46th |
Industry group Drugs | 897 out of 1,730 | 48th |
Industry In Vitro and In Vivo Diagnostic Substances | 36 out of 72 | 50th |
Source: SEC filing on March 15, 2019.
Orlandi's colleagues
We found four more compensation records of executives who worked with Cesare Orlandi at Lantheus Holdings in 2017.